When patients are started on darbepoetin alfa (Aranesp) they need monitoring of their blood counts to determine a dosage adjustment in:
A) 6 weeks if they are a cancer patient
B) 1 week if they have chronic renal failure
C) 2 weeks if they are taking it for allogenic transfusion
D) Each week throughout therapy
Correct Answer:
Verified
Q4: Patients with pernicious anemia require treatment with:
A)
Q5: Monitoring for a patient being prescribed iron
Q6: The routine monitoring recommended for low molecular
Q7: Patients who are being treated with epoetin
Q8: The safest drug to use to treat
Q10: Cecil and his wife are traveling to
Q11: The FDA issued a safety announcement regarding
Q12: Jim is having a hip replacement surgery
Q13: Kenneth is taking warfarin and is asking
Q14: Robert, age 51 years, has been told
Unlock this Answer For Free Now!
View this answer and more for free by performing one of the following actions
Scan the QR code to install the App and get 2 free unlocks
Unlock quizzes for free by uploading documents